The Al Rantisi Hospital, Gaza City’s last pediatric facility, was struck by Israeli drones earlier this week, forcing most ...
FOX 5 Atlanta on MSN
Off-roaders rally for North Georgia man battling rare neurological disease
Dozens of Jeeps, Land Rovers, a Pinzgauer and other vehicles used for off-roading lined up outside a Walmart in Holly Springs ...
This Weird Walking Trick Might Be The Health Boost You Didn’t Know You Needed, Says Longevity Doctor
A 2021 study found that older adults walking on rough paths improved their gait stability by 22%. A separate trial revealed ...
A large international study shows that the accumulation of social hardships across life—known as the social exposome—has ...
12d
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for ...
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New th ...
Discover how robotic gait trainers are transforming rehabilitation for gait disabilities in India, offering hope, recovery, ...
For decades, scientists have worked to peer deeper into the brain. They have wanted to see not just surface activity in the ...
Driven by climate change, population mobility and global trade, mosquito-borne diseases are extending beyond tropical and ...
A leading neurologist involved in development of Alterity's lead compound ATH434 believes it could be a game changer for sufferers of MSA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback